These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 22875827)

  • 41. Developments towards effective treatments for Nipah and Hendra virus infection.
    Bossart KN; Broder CC
    Expert Rev Anti Infect Ther; 2006 Feb; 4(1):43-55. PubMed ID: 16441208
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Distinct VSV-based Nipah virus vaccines expressing either glycoprotein G or fusion protein F provide homologous and heterologous protection in a nonhuman primate model.
    de Wit E; Feldmann F; Cronin J; Goldin K; Mercado-Hernandez R; Williamson BN; Meade-White K; Okumura A; Callison J; Weatherman S; Rosenke R; Avanzato VA; Lovaglio J; Scott DP; Marzi A; Feldmann H
    EBioMedicine; 2023 Jan; 87():104405. PubMed ID: 36508878
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A recombinant VSV-vectored vaccine rapidly protects nonhuman primates against lethal Nipah virus disease.
    Foster SL; Woolsey C; Borisevich V; Agans KN; Prasad AN; Deer DJ; Geisbert JB; Dobias NS; Fenton KA; Cross RW; Geisbert TW
    Proc Natl Acad Sci U S A; 2022 Mar; 119(12):e2200065119. PubMed ID: 35286211
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pathogenic Differences between Nipah Virus Bangladesh and Malaysia Strains in Primates: Implications for Antibody Therapy.
    Mire CE; Satterfield BA; Geisbert JB; Agans KN; Borisevich V; Yan L; Chan YP; Cross RW; Fenton KA; Broder CC; Geisbert TW
    Sci Rep; 2016 Aug; 6():30916. PubMed ID: 27484128
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Protection against henipaviruses in swine requires both, cell-mediated and humoral immune response.
    Pickering BS; Hardham JM; Smith G; Weingartl ET; Dominowski PJ; Foss DL; Mwangi D; Broder CC; Roth JA; Weingartl HM
    Vaccine; 2016 Sep; 34(40):4777-86. PubMed ID: 27544586
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Passive immunization and active vaccination against Hendra and Nipah viruses.
    Broder CC
    Dev Biol (Basel); 2013; 135():125-38. PubMed ID: 23689890
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Single injection recombinant vesicular stomatitis virus vaccines protect ferrets against lethal Nipah virus disease.
    Mire CE; Versteeg KM; Cross RW; Agans KN; Fenton KA; Whitt MA; Geisbert TW
    Virol J; 2013 Dec; 10():353. PubMed ID: 24330654
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Indirect ELISA based on Hendra and Nipah virus proteins for the detection of henipavirus specific antibodies in pigs.
    Fischer K; Diederich S; Smith G; Reiche S; Pinho Dos Reis V; Stroh E; Groschup MH; Weingartl HM; Balkema-Buschmann A
    PLoS One; 2018; 13(4):e0194385. PubMed ID: 29708971
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A recombinant subunit vaccine formulation protects against lethal Nipah virus challenge in cats.
    McEachern JA; Bingham J; Crameri G; Green DJ; Hancock TJ; Middleton D; Feng YR; Broder CC; Wang LF; Bossart KN
    Vaccine; 2008 Jul; 26(31):3842-52. PubMed ID: 18556094
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Transcriptome Profiling of the Virus-Induced Innate Immune Response in Pteropus vampyrus and Its Attenuation by Nipah Virus Interferon Antagonist Functions.
    Glennon NB; Jabado O; Lo MK; Shaw ML
    J Virol; 2015 Aug; 89(15):7550-66. PubMed ID: 25972557
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Third Helical Domain of the Nipah Virus Fusion Glycoprotein Modulates both Early and Late Steps in the Membrane Fusion Cascade.
    Zamora JLR; Ortega V; Johnston GP; Li J; André NM; Monreal IA; Contreras EM; Whittaker GR; Aguilar HC
    J Virol; 2020 Sep; 94(19):. PubMed ID: 32669342
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Receptor binding, fusion inhibition, and induction of cross-reactive neutralizing antibodies by a soluble G glycoprotein of Hendra virus.
    Bossart KN; Crameri G; Dimitrov AS; Mungall BA; Feng YR; Patch JR; Choudhary A; Wang LF; Eaton BT; Broder CC
    J Virol; 2005 Jun; 79(11):6690-702. PubMed ID: 15890907
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Current progress towards prevention of Nipah and Hendra disease in humans: A scoping review of vaccine and monoclonal antibody candidates being evaluated in clinical trials.
    Rodrigue V; Gravagna K; Yao J; Nafade V; Basta NE
    Trop Med Int Health; 2024 May; 29(5):354-364. PubMed ID: 38415314
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hendra and Nipah infection: emerging paramyxoviruses.
    Aljofan M
    Virus Res; 2013 Nov; 177(2):119-26. PubMed ID: 23954578
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Peripheral immune response in the African green monkey model following Nipah-Malaysia virus exposure by intermediate-size particle aerosol.
    Lara A; Cong Y; Jahrling PB; Mednikov M; Postnikova E; Yu S; Munster V; Holbrook MR
    PLoS Negl Trop Dis; 2019 Jun; 13(6):e0007454. PubMed ID: 31166946
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Detailed analysis of the African green monkey model of Nipah virus disease.
    Johnston SC; Briese T; Bell TM; Pratt WD; Shamblin JD; Esham HL; Donnelly GC; Johnson JC; Hensley LE; Lipkin WI; Honko AN
    PLoS One; 2015; 10(2):e0117817. PubMed ID: 25706617
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Recombinant vesicular stomatitis virus-vectored vaccine induces long-lasting immunity against Nipah virus disease.
    Woolsey C; Borisevich V; Fears AC; Agans KN; Deer DJ; Prasad AN; O'Toole R; Foster SL; Dobias NS; Geisbert JB; Fenton KA; Cross RW; Geisbert TW
    J Clin Invest; 2023 Feb; 133(3):. PubMed ID: 36445779
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hendra and Nipah viruses: pathogenesis and therapeutics.
    Eaton BT; Broder CC; Wang LF
    Curr Mol Med; 2005 Dec; 5(8):805-16. PubMed ID: 16375714
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Use of monoclonal antibodies against Hendra and Nipah viruses in an antigen capture ELISA.
    Chiang CF; Lo MK; Rota PA; Spiropoulou CF; Rollin PE
    Virol J; 2010 Jun; 7():115. PubMed ID: 20525276
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Neutralization assays for differential henipavirus serology using Bio-Plex protein array systems.
    Bossart KN; McEachern JA; Hickey AC; Choudhry V; Dimitrov DS; Eaton BT; Wang LF
    J Virol Methods; 2007 Jun; 142(1-2):29-40. PubMed ID: 17292974
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.